Area:
Rheumatoid Arthritis

Therapy Selection in RA: From Clinical Trials to Effectiveness in Practice

Organization:
University of California, San Diego

The overall goal of this educational initiative is to enable community-based practicing rheumatologists and other clinicians involved in the care of patients with rheumatoid arthritis (RA) to select appropriate treatments (mono- and combination therapies) based on critical appraisal and application of data on effectiveness of disease-modifying anti-rheumatic drugs (DMARDs) in real-life practice settings.

The aims of the educational initiative are to improve clinician knowledge and performance with the following aspects of clinical care for patients with RA:

1. Synthesize and analyze factors for the benefits and risks of mono- versus combination DMARD therapy in the management of patients with RA
2. Interpret recent evidence-based data from patient registries and pragmatic clinical trials in RA regarding mono- vs. combination strategies to inform decision-making in practice
3. Identify practical strategies for monitoring disease activity and for achieving target goals of therapy using available DMARDs in patients with RA

Full ProposalInterim ReportsFinal Report
Approval Date:
December 2013
Amount Awarded:
$495,400.00
Start Date:
03/04/2014
End Date:
09/26/2015
Status:
Complete
RFP:
Mono vs Combo DMARD Therapy
RFP ID:
2013RA3